Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept for prevention of new lupus flares in active systemic lupus erythematosus
ACTRN12605000692639Phase 2Recruiting
- Sponsor
- Bristol Myers Squibb
- Start
- Oct 2005
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of abatacept in systemic lupus erythematosus (SLE), sponsored by Bristol Myers Squibb. Started Oct 2005; status: recruiting.
02
Drugs
abatacept
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on ACTRN12605000692639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12605000692639.